Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Auteurs » - entrée « Tsuyoshi Kasama »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Tsuyoshi Iwasaki < Tsuyoshi Kasama < Tsuyoshi Nishiume  Facettes :

List of bibliographic references indexed by Tsuyoshi Kasama

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000994 (2019) Yuzo Ikari ; Takeo Isozaki ; Yumi Tsubokura ; Tsuyoshi KasamaPeficitinib Inhibits the Chemotactic Activity of Monocytes via Proinflammatory Cytokine Production in Rheumatoid Arthritis Fibroblast-Like Synoviocytes
001869 (2017) Yusuke Miwa [Japon] ; Mayu Saito [Japon] ; Hidekazu Furuya [Japon] ; Ryo Yanai [Japon] ; Yuzo Ikari [Japon] ; Tomoki Hayashi [Japon] ; Tsuyoshi Kasama [Japon] ; Yoichi Toyoshima [Japon] ; Katsunori Inagaki [Japon]Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission after Six Months of Non-tumor Necrosis Factor Biological Disease-Modifying Antirheumatic Drugs (DMARDs) Treatment.
001929 (2017) Takeo Isozaki ; Shinichiro Nishimi ; Airi Nishimi ; Mayu Saito ; Yusuke Miwa ; Yoichi Toyoshima [Japon] ; Katsunori Inagaki [Japon] ; Tsuyoshi KasamaA disintegrin and metalloproteinase (ADAM)-10 as a predictive factor for tocilizumab effectiveness in rheumatoid arthritis.
001C34 (2016) Tsuyoshi Kasama [Japon] ; Takeo Isozaki [Japon] ; Ryo Takahashi [Japon] ; Yusuke Miwa [Japon]Clinical effects of tocilizumab on cytokines and immunological factors in patients with rheumatoid arthritis.
001F70 (2015) Atsushi Ogata ; Koichi Amano ; Hiroaki Dobashi ; Masayuki Inoo ; Tomonori Ishii ; Tsuyoshi Kasama ; Shinichi Kawai ; Atsushi Kawakami ; Tatsuya Koike ; Hisaaki Miyahara ; Toshiaki Miyamoto ; Yasuhiko Munakata ; Akira Murasawa ; Norihiro Nishimoto ; Noriyoshi Ogawa ; Tomohiro Ojima ; Hajime Sano ; Kenrin Shi ; Eisuke Shono ; Eiichi Suematsu ; Hiroki Takahashi ; Yoshiya Tanaka ; Hiroshi Tsukamoto ; Akira NomuraLongterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study.
002349 (2014) Tsuyoshi Kasama [Japon] ; Sakiko Isojima ; Masayu Umemura ; Hiroyuki Tsukamoto ; Takehiro Tokunaga ; Hidekazu Furuya ; Ryo Yanai ; Ryo Takahashi ; Masanori Nakamura ; Katsunori InagakiSerum macrophage migration inhibitory factor levels are correlated with response to tocilizumab therapy in patients with rheumatoid arthritis.
003705 (2012) Tsuyoshi Kasama [Japon] ; Hidekazu Furuya [Japon] ; Ryo Yanai [Japon] ; Kumiko Ohtsuka [Japon] ; Ryo Takahashi [Japon] ; Nobuyuki Yajima [Japon] ; Yusuke Miwa [Japon] ; Kazuo Kobayashi [Japon]Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Tsuyoshi Kasama" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Tsuyoshi Kasama" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Tsuyoshi Kasama
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021